Inhibitors of rsv replication and applications thereof
Номер патента: EP3787617A1
Опубликовано: 10-03-2021
Автор(ы): Dennis Liotta, Edgars JECS, Julien SOURIMANT, Richard PLEMPER, Robert Wilson, Stephen PELLY, Zackery Will Dentmon
Принадлежит: EMORY UNIVERSITY, Georgia State University Research Foundation Inc
Опубликовано: 10-03-2021
Автор(ы): Dennis Liotta, Edgars JECS, Julien SOURIMANT, Richard PLEMPER, Robert Wilson, Stephen PELLY, Zackery Will Dentmon
Принадлежит: EMORY UNIVERSITY, Georgia State University Research Foundation Inc
Реферат: Disclosed herein are compounds having antiviral activity, and, in particular, an inhibitory activity on the replication of Respiratory Syncytial Virus (RSV). Druggable target sites, including Px, in the RSV N protein are disclosed, as well as compounds targeting Px. The compounds can be used to treat patients with RSV infection.
Inhibitors of sars-cov-2 viral replication and uses thereof
Номер патента: US20240261307A1. Автор: Rui Chang,Yanyun Liu,Ramachandran VIJAYAN,Patrick RONALDSON,Dominik SCHENTEN. Владелец: University of Arizona. Дата публикации: 2024-08-08.